Activity

Filter

Cancel
Date Panel Item Activity
9 actions
Genetic Epilepsy v0.1821 CLDN5 Zornitza Stark Marked gene: CLDN5 as ready
Genetic Epilepsy v0.1821 CLDN5 Zornitza Stark Gene: cldn5 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1821 CLDN5 Zornitza Stark Phenotypes for gene: CLDN5 were changed from seizures; developmental delay; microcephaly; brain calcifications to Syndromic disorder, MONDO:0002254, CLDN5-related
Genetic Epilepsy v0.1820 CLDN5 Zornitza Stark Mode of pathogenicity for gene: CLDN5 was changed from None to None
Genetic Epilepsy v0.1819 CLDN5 Zornitza Stark Mode of pathogenicity for gene: CLDN5 was changed from Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments to None
Genetic Epilepsy v0.1818 CLDN5 Zornitza Stark Classified gene: CLDN5 as Green List (high evidence)
Genetic Epilepsy v0.1818 CLDN5 Zornitza Stark Gene: cldn5 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1817 CLDN5 Zornitza Stark reviewed gene: CLDN5: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Syndromic disorder, MONDO:0002254, CLDN5-related; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Genetic Epilepsy v0.1817 CLDN5 Suliman Khan gene: CLDN5 was added
gene: CLDN5 was added to Genetic Epilepsy. Sources: Literature
Mode of inheritance for gene: CLDN5 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: CLDN5 were set to PMID: 36477332
Phenotypes for gene: CLDN5 were set to seizures; developmental delay; microcephaly; brain calcifications
Penetrance for gene: CLDN5 were set to Complete
Mode of pathogenicity for gene: CLDN5 was set to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Review for gene: CLDN5 was set to GREEN
Added comment: PMID: 36477332 identified de novo heterozygous missense variants in CLDN5 in fifteen unrelated patients who presented with a shared constellation of features including developmental delay, seizures (primarily infantile onset focal epilepsy), microcephaly and a recognizable pattern of pontine atrophy and brain calcifications.
Sources: Literature